Effect of ocular hypertension on retinal nitridergic pathway activity

Invest Ophthalmol Vis Sci. 2007 May;48(5):2127-33. doi: 10.1167/iovs.06-1229.

Abstract

Purpose: Understanding the mechanisms of neuronal cell death in glaucoma is important for devising new treatments. Excitatory amino acids, excessive Ca(2+) influx, and formation of nitric oxide (NO) via NO synthase (NOS)-1 could be involved in glaucomatous neuropathy. The purpose of the present study was to examine the retinal nitridergic pathway activity in rats exposed to experimentally elevated intraocular pressure.

Methods: Weekly injections of HA were performed unilaterally in the rat anterior chamber, whereas the contralateral eye was injected with saline solution. At 3 or 6 weeks of treatment, retinal NOS activity was assessed through the conversion of (3)H-L-arginine to (3)H-L-citrulline, whereas NOS-1, -2, and -3 levels were assessed by Western blotting. L-Arginine uptake was measured using (3)H-l-arginine, whereas mRNA levels of L-arginine transporters were determined by semiquantitative RT-PCR. In addition, cyclic guanosine monophosphate (cGMP) levels were quantified by radioimmunoassay.

Results: At both 3 and 6 weeks of treatment, NOS activity significantly increased in HA-injected eyes although no changes in retinal NOS-1, -2, or -3 levels were observed in eyes injected with HA. L-Arginine influx and mRNA levels of cationic amino acid transporter type (CAT)-1 and -2 significantly increased in retinas from hypertensive eyes. Retinal cGMP levels significantly increased in eyes injected with HA for 3 but not 6 weeks.

Conclusions: These results suggest a significant activation of the retinal nitridergic pathway in hypertensive eyes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Transport Systems, Basic / metabolism
  • Animals
  • Anterior Chamber / drug effects
  • Arginine / metabolism
  • Blotting, Western
  • Citrulline / metabolism
  • Cyclic GMP / metabolism
  • Disease Models, Animal
  • Hyaluronic Acid / toxicity
  • Intraocular Pressure
  • Male
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase / metabolism*
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type II / metabolism*
  • Nitric Oxide Synthase Type III / metabolism*
  • Ocular Hypertension / chemically induced
  • Ocular Hypertension / metabolism*
  • RNA, Messenger / metabolism
  • Radioimmunoassay
  • Rats
  • Rats, Wistar
  • Retina / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Amino Acid Transport Systems, Basic
  • RNA, Messenger
  • Citrulline
  • Nitric Oxide
  • Hyaluronic Acid
  • Arginine
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos1 protein, rat
  • Nos2 protein, rat
  • Nos3 protein, rat
  • Cyclic GMP